Dr. Narjes Rashidi | Biomaterials | Best Researcher Award

Posted on by ScienceFather

Dr. Narjes Rashidi | Biomaterials | Best Researcher Award

Dr. Narjes Rashidi, University College London, United Kingdom

Dr. Narjes Rashidi is a distinguished biomaterials scientist specializing in tissue engineering and regenerative medicine. Her groundbreaking research focuses on osteochondral scaffolds, aiming to regenerate both bone and cartilage simultaneously. With an academic background from Oxford and Imperial College London, she has made significant contributions to biomimetic materials and hydrogels for medical applications. Dr. Rashidi’s interdisciplinary expertise in chemical engineering and biomedical sciences has driven advancements in stem cell therapy and extracellular matrix design. Actively engaging in global research collaborations and conferences, she remains committed to pioneering solutions for musculoskeletal disorders.

Professional Profile:

Orcid

Suitability for Best Researcher Award

Dr. Narjes Rashidi is a highly accomplished biomaterials scientist with an impressive background in tissue engineering, regenerative medicine, and biomimetic materials. Her groundbreaking research on osteochondral scaffolds for simultaneous bone and cartilage regeneration makes her an excellent candidate for the Best Researcher Award. With academic credentials from Oxford and Imperial College London, interdisciplinary expertise, and global research collaborations, she has made significant contributions to biomedical science.

πŸŽ“ Education & Experience:

  • Ph.D. in Biomaterials (2013-2018) πŸŽ“ – University of Oxford

    • πŸ“ Thesis: Design and Fabrication of Novel Osteochondral Plug for Bone & Cartilage Regeneration

  • MSc in Biomedical Engineering (2010-2011) πŸŽ“ – Imperial College London

    • πŸ“ Thesis: New Bioactive Glass Scaffold for Bone Regeneration

  • MSc in Chemical Engineering (2002-2005) πŸ—οΈ – Tarbiat Modares University

    • πŸ“ Thesis: Software Package for Conceptual Design of Chemical Processes

  • BSc in Chemical Engineering (1997-2002) 🏭 – Sharif University of Technology

    • πŸ“ Thesis: Plant Design for Palm Waste Utilization

  • Postdoctoral Research Fellow (2022-2023) πŸ§ͺ – University of Brighton

  • Postdoctoral Research Associate (2020-2021) πŸ”¬ – Tehran University of Medical Sciences & UCL Collaboration

  • Part-time Researcher (Feb-Apr 2021) πŸ₯ – ChitoTech (Medical Device Company), Tehran

  • Business Development Manager (2011-2013) πŸ’Ό – Avalin Pharma, Tehran

πŸ“š Professional Development:

Dr. Rashidi is dedicated to continuous learning and innovation in biomaterials and tissue engineering. She actively participates in workshops, training programs, and international conferences to stay at the forefront of regenerative medicine and scaffold fabrication techniques. Her interdisciplinary collaborations have enriched her approach to hydrogel and stem cell research, ensuring clinical relevance in biomedical applications. Dr. Rashidi frequently engages in scientific symposiums, sharing her expertise on biomimetic scaffolds and extracellular vesicles. Her passion for scientific discovery and technological advancements drives her to develop pioneering solutions for musculoskeletal and orthopedic disorders.

πŸ”¬ Research Focus:

Dr. Rashidi’s research revolves around biomimetic materials and regenerative medicine, particularly in tissue engineering. She specializes in hydrogel-based scaffolds that closely mimic the extracellular matrix, enhancing cell differentiation and tissue regeneration. Her osteochondral scaffold research focuses on simultaneous bone and cartilage repair, addressing major challenges in orthopedic medicine. She also investigates plant-based extracellular vesicles for osteoarthritis treatment, expanding her contributions to stem cell therapy and bioactive materials. Her interdisciplinary approach merges biomedical engineering, materials science, and chemical engineering, ensuring her work bridges laboratory research with clinical applications.

πŸ† Awards & Honors:

  • Best Breakthrough Actress Award (2007) πŸ… – New York Independent International Film & Video Festival
  • Best Actress in an International Film (2016) 🎭 – BloodGuts UK Horror Award
  • Best Actress Nomination (2016) 🎬 – British Independent Film Awards

Publication Top Notes:

  • 🦠 “Isolation, Characterization, and In Vitro Cell Studies of Plant-Based Exosome-like Nanovesicles for Treatment of Early Osteoarthritis”
  • 🧬 “A novel, microfluidic high-throughput single-cell encapsulation of human bone marrow mesenchymal stromal cells”
  • πŸ§ͺ “Polymerization of chondroitin sulfate and its stimulatory effect on cartilage regeneration; a bioactive material for cartilage regeneration”
  • 🦴 “A Bilayer Osteochondral Scaffold with Self‐Assembled Monomeric Collagen Type‐I, Type‐II, and Polymerized Chondroitin Sulfate Promotes Chondrogenic and Osteogenic Differentiation of Mesenchymal Stem Cells”

 

Prof. Xiaolei Wang | Biomedical | Best Researcher Award

Posted on by ScienceFather

Prof. Xiaolei Wang | Biomedical | Best Researcher Award

Prof Xiaolei Wang, Nanchang University, China

Professor Xiaolei Wang is a distinguished researcher at Nanchang University, specializing in photo-responsive materials for biomedical applications. Holding a Ph.D. from the Changchun Institute of Applied Chemistry (2009) under Academician Yang Xiurong, he is recognized as a National Talent and a Changjiang Young Scholar. He serves as Dean of Jiluan College and Deputy Director of the National-Local Joint Center for Bioengineering Drugs and Technologies. With over 130 publications in top-tier journals like Advanced Materials and ACS Nano, 42 patents, and multiple prestigious awards, his groundbreaking research bridges academia and industry, driving impactful innovations in nanomedicine. πŸš€

Professional Profile:

Scopus

Suitability for Best Researcher Award

Professor Xiaolei Wang is a highly accomplished researcher in photo-responsive materials for biomedical applications. His extensive contributions to nanomedicine, regenerative medicine, and antimicrobial technologies demonstrate a profound impact on both academic research and industry. With 130+ high-impact publications, 42 patents, and leadership roles in prestigious institutions, he has consistently driven innovation and interdisciplinary collaboration. His recognition as a National Talent and Changjiang Young Scholar further cements his influence in the scientific community.

Education & Experience πŸŽ“πŸ‘¨β€πŸ«

  • πŸŽ“ Ph.D. in Applied Chemistry (2009) – Changchun Institute of Applied Chemistry, under Academician Yang Xiurong
  • πŸ“š Dean, Jiluan College – Nanchang University
  • πŸ₯ Deputy Director – National-Local Joint Center for Bioengineering Drugs and Technologies
  • πŸ‘¨β€πŸ”¬ Professor – Nanchang University
  • πŸ“– Research Collaborator – Chinese PLA General Hospital, First Affiliated Hospital of Nanchang University, and Institute of Biomedical Innovation

Professional Development πŸš€

Professor Xiaolei Wang has made pioneering contributions to biomedical applications of photo-responsive materials, leading 16 major research projects and publishing 161 SCI-indexed papers. His collaborative projects with top research institutions focus on advanced wound healing, Helicobacter pylori treatment, and neurobiological enhancements. As a recognized National Talent and Changjiang Young Scholar, he bridges cutting-edge research with industry applications, collaborating with China National Pharmaceutical Group and Guangyuan Group. His work in zinc oxide research has transformed its optical properties for biomedical use, earning accolades like the China Hi-Tech Fair Outstanding Product Award. His innovations continue to drive impactful scientific advancements. 🌟

Research FocusΒ  πŸ”¬

Professor Xiaolei Wang’s research revolves around photo-responsive materials in biomedicine, particularly in wound healing, antibacterial therapy, and neurological treatments. His breakthrough studies on light-activated artificial skin have set new standards in regenerative medicine. His work on metal-organic framework-based hydrogen-release platforms for targeted bacterial infections is a pioneering approach in antimicrobial nanotechnology. His photo- and magnetic-responsive nasal delivery systems for mental health treatments are redefining non-invasive therapeutic strategies. With a strong interdisciplinary approach, his research integrates materials science, nanotechnology, and medicine, shaping the future of next-generation biomedical treatments. 🧬✨

Awards & Honors πŸ…

  • πŸ† National Hundred, Thousand, and Ten Thousand Talents Project – Recognized as a National Talent
  • πŸ… Changjiang Young Scholar Award – Prestigious academic honor
  • πŸ† First Prize of Natural Science (2012) – Jilin Province
  • πŸ… First Prize of Medical Technology (2021) – Jiangxi Province
  • πŸ† China Hi-Tech Fair Outstanding Product Award – Recognition for innovation
  • πŸ… 2024 Outstanding Paper Award – Advanced Sensor and Energy Materials
  • πŸ† 42 Patents – Innovations in nanomedicine and materials science

Publication Top Notes:

  • 🦷 Yellow light and ultrasound dual-responsive strontium-doped zinc oxide composites for dental caries prevention and remineralization
  • 🍺 Cold beer-inspired multifunctional nanozyme for ischemic stroke with rapid thrombus clearance and long-lasting hydrogen therapy
  • 🩹 A molybdenum sulfide-based nitric oxide controlled release oral gel for rapid healing of oral mucosal ulcers
  • 🦴 Time-dependent electrical active and ultrasound-responsive calcium titanate implant coating with immunomodulation, osteogenesis, and customized antibacterial activity
  • 🦾 Inflammatory microenvironment regulation and osteogenesis promotion by bone-targeting calcium and magnesium repletion nanoplatform for osteoporosis therapy – πŸ“‘ 1 citation

 

Ms. Moloud Farrokhi | Nanodelivery Awards | Best Researcher Award

Posted on by ScienceFather

Ms. Moloud Farrokhi | Nanodelivery Awards | Best Researcher Award

Ms. Moloud Farrokhi , Albany Medical college, United States

Mouloud Farrokhi is an experienced immunologist and microbiologist specializing in HIV/AIDS research, nanoparticle delivery systems, and viral infections. He is currently pursuing a PhD in Biology with a focus on Immunology and Microbiology at Albany Medical College, USA. Mouloud has a strong academic and professional background, having worked as a research assistant and medical laboratory scientist in Iran and Sweden. His research aims to improve understanding and treatment of viral infections, with significant contributions to HIV drug resistance and oncolytic virus therapy. Mouloud’s work also extends to the development of innovative nanoparticle-based drug delivery systems, offering promising solutions for invasive infections like Aspergillosis. His expertise spans from molecular biology to clinical research, with an emphasis on laboratory techniques like PCR, qRT-PCR, NGS, and CRISPR/Cas9.

Professional Profile:

Google Scholar

Mouloud Farrokhi: A Strong Contender for the Research Best Researcher Award

Mouloud Farrokhi is an exceptional candidate for the Research Best Researcher Award due to his extensive background in immunology, microbiology, and viral infections, as well as his significant contributions to molecular diagnostics and therapeutic innovations. His educational qualifications, research experience, and recognition in the field of medical sciences make him a highly suitable candidate for this prestigious award.

πŸŽ“Education:

Mouloud Farrokhi is currently pursuing a PhD in Biology, specializing in Immunology and Microbiology at Albany Medical College, USA (2023–Present). He holds two Master’s degrees: an MSc in Bioscience from the University of SkΓΆvde, Sweden (2021–2022), with a thesis on the role of RABL6 in AP3-dependent trafficking, and an MSc in Cellular and Molecular Biology from the Islamic Azad University, Iran (2010–2014), where he researched HIV-1 drug resistance. His undergraduate studies were in Marine Biology at the Islamic Azad University, Tehran, Iran (2003–2008). Mouloud’s extensive education in biological sciences provides a solid foundation for his current research endeavors, focusing on viral infections, molecular diagnostics, and therapeutic innovations.

🏒Experience:

Mouloud Farrokhi has gained extensive experience as a research assistant and medical laboratory scientist. He worked as a Research Assistant at Tehran University of Medical Sciences (2022–2023), where he focused on statistical analysis and NGS (Next Generation Sequencing). He has also served as a Medical Laboratory Assistant at Tehran University of Medical Sciences (2018–2021), where he conducted HIV viral load analysis and COVID-19 testing via qPCR. His previous roles include being a Medical Laboratory Scientist at Dena Lab (2017–2018), where he performed NITP tests and a Research Assistant at Pasteur Institute of Iran (2016–2017), where he researched drug resistance in HIV and HCV. He has also contributed to laboratory work at Keyvan Virology Laboratory, Tehran (2015–2016). Mouloud’s diverse hands-on experience makes him proficient in molecular biology techniques, data analysis, and lab management.

πŸ…Awards and Honors:

Mouloud Farrokhi’s academic and research achievements are reflected in his high academic standing and contributions to scientific research. His thesis at the University of SkΓΆvde received top marks, with a GPA of 3.75, and he has consistently demonstrated excellence throughout his academic career. His research contributions have been recognized in various publications and presentations. Notably, he presented at the International Student Congress in Medical Sciences (ISCOM) in 2017 and at the Upstate New York Immunology Conference (NYIC) in 2024. Mouloud’s work in HIV drug resistance and nanoparticle drug delivery systems has been published in high-impact journals. His dedication to advancing medical science has led to multiple research opportunities, including participation in workshops on gene transfer and vaccine design.

πŸ”¬Research Focus:

Mouloud Farrokhi’s research focuses on immunology, microbiology, and the molecular mechanisms underlying viral infections and drug resistance. He investigates the molecular pathways of HIV and other viral infections, focusing on drug resistance mechanisms in HIV-1 and HCV. His research also explores innovative strategies for oncolytic virus therapy and nanoparticle-based drug delivery, with the goal of improving treatment outcomes for invasive infections like Aspergillosis. Additionally, he is involved in genetic analysis and genomic editing technologies such as CRISPR/Cas9. Mouloud’s work integrates molecular diagnostics and therapeutic advancements, contributing significantly to both basic science and clinical applications in virology and immunology.

Publication Top Notes:

  • “Subtype classification of Iranian HIV-1 sequences registered in the HIV databases, 2006-2013”
    • Citations: 31
  • “HIV drug resistance among naΓ―ve HIV-infected patients in Iran”
    • Citations: 14
  • “Antiretroviral drug resistance mutations among HIV treatment failure patients in Tehran, Iran”
    • Citations: 11
  • “The first characterization of HIV-1 subtypes and drug resistance mutations among antiretrovirally treated patients in Kermanshah, Iran”
    • Citations: 9
  • “HIV drug resistance and phylogeny profile in naive and antiretroviral-experienced patients in Tehran, Iran”
    • Citations: 8

 

 

 

Mr. Jose M Soriano | Nanobiotechnology Awards | Best Researcher Award

Posted on by ScienceFather

Mr. Jose M Soriano | Nanobiotechnology Awards | Best Researcher Award

Mr. Jose M Soriano, University of Valencia, Spain

José Miguel Soriano del Castillo,  is a distinguished full professor in food safety, toxicology, and nutritional sciences at the Universitat de València. Holding a Licenciatura in Pharmacy and a Ph.D. in Food Safety, he has dedicated his career to advancing public health through food science and toxicology. Soriano is recognized for his extensive research on pathogenic food agents, toxicity in food items, and essential nutrients, making him a key figure in food safety and toxicology. His collaborative work has significantly influenced food quality standards and safety protocols globally. A fluent speaker of Valencian/Catalan, he is a member of various prestigious academic societies and has published extensively in high-impact journals.

Professional Profile:

Orcid

Scopus

Β Best Researcher Awards: JosΓ© Miguel Soriano del Castillo

Summary of Suitability for the Award:

JosΓ© Miguel Soriano del Castillo’s extensive and impactful research in the fields of food safety, toxicology, and nutritional sciences positions him as an outstanding candidate for the Best Researcher Award. His academic background, which includes a Licenciatura in Pharmacy and a Ph.D. in Food Safety, demonstrates a strong foundation in both theoretical knowledge and practical applications relevant to public health.

πŸŽ“Education:

Soriano completed his Licenciatura in Pharmacy at the Facultat de Farmacia, Universitat de València, in 1996. Building on his expertise, he pursued a Ph.D. in Food Safety at the same institution, which he completed in 2001. To further expand his knowledge, he earned a degree in Human Nutrition and Dietetics from Universidad Cardenal Herrera-CEU in 2018. His academic journey reflects a commitment to understanding the intricate relationships between food, nutrition, and public health. With a strong foundation in pharmacy, Soriano specializes in food toxicology and safety, integrating interdisciplinary insights from his studies into his current research and teaching.

🏒Experience:

Soriano began his career in 1996 as a researcher at the Laboratorio de Bromatología, Facultat de Farmacia, Universitat de València, where he conducted essential food safety studies until 2001. His career evolved with his appointment as a full professor on November 15, 2019, at the Universitat de València. In this role, he contributes to the field through research in food science, public health, and toxicology. Soriano has also served in advisory capacities, lending his expertise to enhance food safety regulations in academic and public health institutions. His dedication to education, coupled with his professional achievements, has greatly impacted his department and students.

πŸ…Awards and Honors:

JosΓ© Miguel Soriano del Castillo has received numerous accolades for his impactful contributions to food safety and toxicology. His pioneering research on food toxicity and nutritional science has earned him recognition in scientific circles. Among his honors are awards for excellence in public health research and commendations from both national and international academic bodies. His work has been frequently cited in food safety protocols, making him a respected authority in the field. Soriano’s commitment to enhancing food safety and public health has cemented his status as a prominent figure in the scientific community.

πŸ”¬Research Focus:

Soriano’s research focuses on identifying and mitigating risks associated with food-borne pathogens, analyzing food toxicity, and assessing essential nutrients. His work aims to improve food safety standards and public health by investigating harmful food contaminants and optimizing detection methods. As a leader in food toxicology, he explores innovative methodologies in high-performance liquid chromatography (HPLC) and other analytical techniques to evaluate pesticides and other hazardous substances in food. His research supports sustainable practices in food production and enhances safety in food supply chains, contributing significantly to public health and nutrition.

Publication Top Notes:

  • NUTRARET: Effect of 2-Year Nutraceutical Supplementation on Redox Status and Visual Function of Patients With Retinitis Pigmentosa: A Randomized, Double-Blind, Placebo-Controlled Trial
    • Citations: 3
  • Nutraceutical supplementation ameliorates visual function, retinal degeneration, and redox status in rd10 mice
    • Citations: 19
  • The BFMNU method as an alternative to the methods in use based on energy: Study of the correlation between food energy and body mass | El mΓ©todo BFMNU como alternativa a los mΓ©todos en uso basados en energΓ­a: Estudio de la correlaciΓ³n entre la energΓ­a alimentaria y la masa corporal
    • Citations: 1
  • Obesity’s causes and treatment | Causas y tratamiento de la obesidad
    • Citations: 16
  • Anthropometric evaluation of adult coeliac patients from de Valencian Community (Spain) | EvaluaciΓ³n antropomΓ©trica de celΓ­acos adultos de la Comunidad Valenciana
    • Citations: 1

 

 

Prof. Franciska Erdo | Drug delivery Award | Best Researcher Award

Posted on by ScienceFather

Prof. Franciska Erdo | Drug delivery Award | Best Researcher Award

Prof. Franciska Erdo , PΓ‘zmΓ‘ny PΓ©ter Catholic University , Hungary

Franciska VidΓ‘nΓ© Dr. ErdΕ‘, born on May 28, 1964, in Budapest, is a distinguished full professor and lab head at PΓ‘zmΓ‘ny PΓ©ter Catholic University, Faculty of Information Technology and Bionics. She holds a PhD in pharmacology from Semmelweis University and has extensive experience in both academic and research institutions, including the University of Tours, CharitΓ© Medizinische UniversitΓ€t in Berlin, and the Max-Planck Institute in Cologne. Her research focuses on drug research and development, evidenced by her numerous fellowships and scholarships. She has supervised over 31 graduate students and postdoctoral fellows and has been recognized for her teaching excellence. Dr. ErdΕ‘ has also contributed significantly to scientific literature and education, particularly in the fields of molecular bionics and biomedical innovation.

Professional Profile:

Orcid

Education:

Franciska VidΓ‘nΓ© Dr. ErdΕ‘ earned her MSc in Pharmacy from Semmelweis University in 1987, graduating with top grades. She continued her education at the same institution, achieving a University Doctor degree in Pharmacology with summa cum laude honors in 1994. In 1997, she completed her PhD in Pharmacology, also with summa cum laude distinction, at Semmelweis University, Faculty of Pharmacy. Most recently, in 2019, she received her habilitation from PΓ‘zmΓ‘ny PΓ©ter Catholic University, Faculty of Information Technology and Bionics.

Work Experience:

Franciska VidΓ‘nΓ© Dr. ErdΕ‘ has held numerous esteemed positions throughout her career. Since 2024, she has been serving as a Full Professor and Lab Head at PΓ‘zmΓ‘ny PΓ©ter Catholic University, Faculty of Information Technology and Bionics. Prior to this, from 2019 to 2024, she was an Associate Professor and Lab Head at the same institution. She was also a Guest Researcher at the University of Tours, France, in 2022. From 2014 to 2019, she worked as a Senior Research Fellow and Lab Head at PΓ‘zmΓ‘ny PΓ©ter Catholic University. Her earlier roles include serving as a Senior Research Fellow and Lab Head at SOLVO Biotechnology from 2007 to 2014, and holding a scientific scholarship at CharitΓ© Medizinische UniversitΓ€t in Berlin, Germany, from 2005 to 2006. She also worked as a Senior Research Fellow at IVAX Drug Research Institute from 2003 to 2007 and held a Max Planck Fellowship at the Max-Planck Institute fΓΌr neurologische Forschung in Cologne, Germany, from 2000 to 2003. Her earlier positions include Senior Research Fellow roles at Sanofi-Synthelabo Chinoin from 1997 to 2000 and Biorex R&D Co. from 1995 to 1997. She began her career as a Research Fellow at the Institute for Drug Research from 1990 to 1995 and as a Junior Research Fellow at the same institute from 1987 to 1990.

Publication Top Notes:

1.Fluid Dynamics Optimization of Microfluidic Diffusion Systems for Assessment of Transdermal Drug Delivery: An Experimental and Simulation Study

  • Journal: Scientia Pharmaceutica
  • Publication Date: June 2024

2. Progress in Topical and Transdermal Drug Delivery Researchβ€”Focus on Nanoformulations

  • Journal: Pharmaceutics
  • Publication Date: June 2024

3. Transdermal Delivery of Ξ±-Aminophosphonates as Semisolid Formulationsβ€”An In Vitro-Ex Vivo Study

  • Journal: Pharmaceutics
  • Publication Date: May 2023

 

 

Assoc. Prof. Dr. Kyeong Soo Kim | Pharmaceutics Awards | Excellence in Research

Posted on by ScienceFather

Assoc. Prof. Dr. Kyeong Soo Kim | Pharmaceutics Awards | Excellence in Research

Assoc. Prof. Dr. Kyeong Soo KimΒ  , Gyongsang National University/Dept. of Pharmaceutical Engineering , South Korea

Kyeong Soo Kim is an accomplished researcher and academic based in the Republic of Korea. He currently serves as an Associate Professor in the Department of Pharmaceutical Engineering at Gyeongsang National University. Dr. Kim earned his Ph.D. in Pharmacy from Hanyang University, where he specialized in the development of novel controlled release formulations for fenofibric acid. His research interests span nanotechnology applications for poorly water-soluble drugs, improved pharmaceutical technologies for controlled release dosage forms, inhaled drug delivery systems, and dermal drug delivery systems. Prior to his current position, he held roles as a Postdoctoral Research Associate at the University of Mississippi and as a Principal Scientist at Hanmi Pharm. Co., Ltd., where he gained extensive experience in formulation and process development. Dr. Kim’s expertise includes designing oral and parenteral dosage forms, conducting preformulation studies, and utilizing advanced techniques such as solid dispersion, spray drying, and lipid-based formulations to enhance drug delivery efficacy. He is actively involved in research and has contributed significantly to the field through his publications and professional engagements.

Professional Profile:

Scopus

πŸŽ“Education:

Kyeong Soo Kim is a distinguished academic and researcher in the field of pharmacy, currently holding the position of Associate Professor at Gyeongsang National University in the Republic of Korea. He completed his Ph.D. in Pharmacy at Hanyang University from March 2011 to August 2015, under the guidance of Professor Han-Gon Choi, Ph.D. His doctoral research focused on the development of innovative controlled release formulations for fenofibric acid. Prior to his doctoral studies, he earned a Master of Science in Pharmacy at Chungbuk National University from March 2002 to August 2004, where his research investigated the depigmenting effects and mechanisms of piperlonguminine derived from Piper longum. Kyeong Soo Kim began his academic journey with a Bachelor of Science in Pharmacy, also from Chungbuk National University, completed from March 1998 to February 2002. His educational background underscores his expertise in pharmaceutical sciences, particularly in drug delivery systems and formulation development.

 🏒Work Experience:

Kyeong Soo Kim is currently an Associate Professor in the Department of Pharmaceutical Engineering at Gyeongsang National University in the Republic of Korea, a position he has held since September 2017. Prior to joining Gyeongsang National University, Dr. Kim served as a Postdoctoral Research Associate at the Department of Pharmaceutics and Drug Delivery, School of Pharmacy, The University of Mississippi, USA, from September 2016 to August 2017. Before his time in the United States, he worked as a Postdoctoral Research Fellow at the Laboratory of Industrial & Physical Pharmacy at Hanyang University, Republic of Korea, from September 2015 to August 2016. Dr. Kim’s extensive professional experience also includes a significant tenure as a Principal Scientist and Team Manager at the Pharmaceutical R&D Center of Hanmi Pharm. Co., Ltd., Republic of Korea, where he contributed from August 2004 to November 2014. His career path highlights his expertise in pharmaceutical engineering, drug delivery systems, and research leadership in both academic and industrial settings.

Publication Top Notes:

  • “Improved bioavailability and high photostability of methotrexate by spray-dried surface-attached solid dispersion with an aqueous medium” by Giri, B.R., Kim, J.S., Park, J.H., … Choi, H.G., Kim, D.W.
    • Journal: Pharmaceutics, 2021, 13(1), pp. 1–14, 111
    • Citations: 36
  • “Nitration of protein phosphatase 2A increases via Epac1/PLCΞ΅/CaMKII/HDAC5/iNOS cascade in human endometrial stromal cell decidualization” by Lee, S.Y., Lee, Y.Y., Choi, J.-S., … Park, S.-Y., Han, J.-S.
    • Journal: FASEB Journal, 2020, 34(11), pp. 14407–14423
    • Citations: 2
  • “Development of Novel d-Cycloserine Tablet with Improvement of Drug Stability and Dissolution-Equivalence to the d-Cycloserine-Loaded Commercial Hard Capsule” by Kim, J.S., Choi, Y.J., Woo, M.R., … Jin, S.G., Choi, H.-G.
    • Journal: Bulletin of the Korean Chemical Society, 2020, 41(6), pp. 603–608
    • Citations: 3
  • “Enhanced Chemical Stability of D-Cycloserine via Tablet Form Containing Magnesium Oxide as an Alkali Stabilizer” by Kim, J.S., Lee, S.M., Kim, D.S., … Jin, S.G., Choi, H.-G.
    • Journal: Bulletin of the Korean Chemical Society, 2020, 41(1), pp. 10–14
    • Citations: 1
  • “Self-microemulsifying drug delivery system (SMEDDS) for improved oral delivery and photostability of methotrexate” by Kim, D.S., Cho, J.H., Park, J.H., … Choi, H.-G., Kim, D.W.
    • Journal: International Journal of Nanomedicine, 2019, 14, pp. 4949–4960
    • Citations: 61